Prime medicine to present at 42nd annual j.p. morgan healthcare conference

Cambridge, mass., jan. 02, 2024 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that keith gottesdiener, m.d., president and chief executive officer of prime medicine, will present a corporate overview at the 42nd annual j.p. morgan healthcare conference on monday, january 8, 2024 at 2:15 p.m. pt (5:15 p.m. et) in san francisco, ca.
PRME Ratings Summary
PRME Quant Ranking